We’ve had great integration of PAT tools on our production line of which IRUBIS Monipa (Mid-IR system) is one of them. IRUBIS Mid-IR is sensitive to CQA’s and byproducts in our IVT reaction, therefore enabling chemometric modelling to predict concentration for those components as well as reaction trend such as endpoint.

It was a great experience to visualize and resolve concentration profiles during our pART pDNA purification platform. We are always excited to pARTner up with innovative science and technology.

Increase product knowledge and process robustness through data connectivity and integrity – this is IRUBIS vision. We are proud to support IRUBIS excellent team with implementation of Monipa’s OPC UA interface to the PAT platform, SIMATIC SIPAT, in LivingLab Vienna.

We developed a solution for inline quality monitoring in the downstream process using a MIR Spectroscopy device, Monipa, from IRUBIS. The past 10 years have shown spectroscopic techniques to be powerful analytical tools for process development and biologics manufacturing.

CPI recognises that the biopharma industry requires the development of novel process analytical technologies (PAT) that can be deployed in and on-line to determine a variety of critical quality attributes and critical process parameters. The Monipa, developed by IRUBIS GmbH, is an example of novel PAT that can be deployed in both upstream and downstream biological applications.

Finally, a great-performing cryogen-free mid-IR device on the market which is boosting inline analysis with excellent stability and a convincing easy of handling. Definitely paving the path to more knowledge-driven process understanding, monitoring and control when combined with our PEAXACT solutions for quantitative analysis!